Jeffrey Farrow serves as the Chief Financial Officer (CFO) and Chief Strategy Officer (CSO) at TARSUS PHARMACEUTICALS INC, a biopharmaceutical company focused on developing and commercializing innovative therapies for ophthalmic, dermatologic, and other underserved diseases. In his dual role, Farrow is responsible for overseeing the company's financial operations, strategic planning, and execution of key initiatives that drive growth and value creation. His strategic oversight is instrumental in guiding TARSUS through its various stages of development and towards its goal of bringing transformative treatments to patients. Before joining TARSUS, Farrow built an impressive career in the life sciences and healthcare sectors. He held significant leadership positions at several notable organizations, where he honed his expertise in finance, strategy, and business development. His previous roles include CFO positions at biotech firms and investment banking, where he advised on mergers and acquisitions, financings, and other strategic transactions. Farrow's deep understanding of the industry, coupled with his financial acumen, has been pivotal in steering TARSUS towards sustainable growth and market expansion. Among his notable achievements, Farrow has successfully led TARSUS through multiple rounds of funding, securing the capital necessary to advance the company’s pipeline and commercial efforts. His strategic vision has also been crucial in forging partnerships and collaborations that enhance TARSUS's research and development capabilities. Under his leadership, TARSUS has made significant strides in advancing its mission to address unmet medical needs, positioning the company as a leader in its therapeutic areas.